These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 32579167)

  • 1. Establishing metastatic patient-derived xenograft model for colorectal cancer.
    Zhang Y; Lee SH; Wang C; Gao Y; Li J; Xu W
    Jpn J Clin Oncol; 2020 Sep; 50(10):1108-1116. PubMed ID: 32579167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of patient-derived orthotopic xenografts from metastatic colorectal cancer in nude mice.
    Roque-Lima B; Roque CCTA; Begnami MD; Peresi P; Lima ENP; Mello CAL; Coimbra FJ; Chojniak R; Goss Santos T
    J Drug Target; 2019 Nov; 27(9):943-949. PubMed ID: 30088428
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Colorectal cancer patient-derived xenografted tumors maintain characteristic features of the original tumors.
    Cho YB; Hong HK; Choi YL; Oh E; Joo KM; Jin J; Nam DH; Ko YH; Lee WY
    J Surg Res; 2014 Apr; 187(2):502-9. PubMed ID: 24332554
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A fast, simple, and cost-effective method of expanding patient-derived xenograft mouse models of pancreatic ductal adenocarcinoma.
    Liu Z; Ahn MH; Kurokawa T; Ly A; Zhang G; Wang F; Yamada T; Sadagopan A; Cheng J; Ferrone CR; Liss AS; Honselmann KC; Wojtkiewicz GR; Ferrone S; Wang X
    J Transl Med; 2020 Jun; 18(1):255. PubMed ID: 32580742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient-derived Orthotopic Xenograft Models for Human Urothelial Cell Carcinoma and Colorectal Cancer Tumor Growth and Spontaneous Metastasis.
    Moret R; Hellmers L; Zhang X; Gills J; Hite N; Klinger A; Maresh GA; Canter D; Bardot S; Margolin DA; Li L
    J Vis Exp; 2019 May; (147):. PubMed ID: 31132059
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive comparison of patient-derived xenograft models in Hepatocellular Carcinoma and metastatic Liver Cancer.
    Xu W; Zhao ZY; An QM; Dong B; Lv A; Li CP; Guan XY; Tian XY; Wu JH; Hao CY
    Int J Med Sci; 2020; 17(18):3073-3081. PubMed ID: 33173428
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Patient-derived cell models as preclinical tools for genome-directed targeted therapy.
    Lee JY; Kim SY; Park C; Kim NK; Jang J; Park K; Yi JH; Hong M; Ahn T; Rath O; Schueler J; Kim ST; Do IG; Lee S; Park SH; Ji YI; Kim D; Park JO; Park YS; Kang WK; Kim KM; Park WY; Lim HY; Lee J
    Oncotarget; 2015 Sep; 6(28):25619-30. PubMed ID: 26296973
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of an orthotopic patient-derived xenograft mouse model using uveal melanoma hepatic metastasis.
    Kageyama K; Ohara M; Saito K; Ozaki S; Terai M; Mastrangelo MJ; Fortina P; Aplin AE; Sato T
    J Transl Med; 2017 Jun; 15(1):145. PubMed ID: 28645290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A personalized preclinical model to evaluate the metastatic potential of patient-derived colon cancer initiating cells.
    Puig I; Chicote I; Tenbaum SP; Arqués O; Herance JR; Gispert JD; Jimenez J; Landolfi S; Caci K; Allende H; Mendizabal L; Moreno D; Charco R; Espín E; Prat A; Elez ME; Argilés G; Vivancos A; Tabernero J; Rojas S; Palmer HG
    Clin Cancer Res; 2013 Dec; 19(24):6787-801. PubMed ID: 24170545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Establishment of Novel Gastric Cancer Patient-Derived Xenografts and Cell Lines: Pathological Comparison between Primary Tumor, Patient-Derived, and Cell-Line Derived Xenografts.
    Kuwata T; Yanagihara K; Iino Y; Komatsu T; Ochiai A; Sekine S; Taniguchi H; Katai H; Kinoshita T; Ohtsu A
    Cells; 2019 Jun; 8(6):. PubMed ID: 31207870
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
    Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
    Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translational pancreatic cancer research: A comparative study on patient-derived xenograft models.
    Rubio-Manzanares Dorado M; Marín Gómez LM; Aparicio Sánchez D; Pereira Arenas S; Praena-Fernández JM; Borrero Martín JJ; Farfán López F; Gómez Bravo MÁ; Muntané Relat J; Padillo Ruiz J
    World J Gastroenterol; 2018 Feb; 24(7):794-809. PubMed ID: 29467550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of Highly Transplantable Cholangiocarcinoma Cell Lines from a Patient-Derived Xenograft Mouse Model.
    Vaeteewoottacharn K; Pairojkul C; Kariya R; Muisuk K; Imtawil K; Chamgramol Y; Bhudhisawasdi V; Khuntikeo N; Pugkhem A; Saeseow OT; Silsirivanit A; Wongkham C; Wongkham S; Okada S
    Cells; 2019 May; 8(5):. PubMed ID: 31126020
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecularly annotation of mouse avatar models derived from patients with colorectal cancer liver metastasis.
    Wang J; Xing B; Liu W; Li J; Wang X; Li J; Yang J; Ji C; Li Z; Dong B; Gao J; Shen L
    Theranostics; 2019; 9(12):3485-3500. PubMed ID: 31281492
    [No Abstract]   [Full Text] [Related]  

  • 15. An improved method to build lung cancer PDX models by surgical resection samples and its association with B7-H3 expression.
    Wang Y; Zhang B; Huang H; Wang T
    Transl Cancer Res; 2019 Dec; 8(8):2848-2857. PubMed ID: 35117042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Establishment of a patient-derived xenograft humanized mouse model for hepatoblastoma in children].
    Hu HM; Zhang WL; Huang DS; Li R; Gu HL; Li J; Gao YN
    Zhonghua Gan Zang Bing Za Zhi; 2023 Oct; 31(10):1075-1080. PubMed ID: 38016773
    [No Abstract]   [Full Text] [Related]  

  • 17. Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.
    Navone NM; van Weerden WM; Vessella RL; Williams ED; Wang Y; Isaacs JT; Nguyen HM; Culig Z; van der Pluijm G; Rentsch CA; Marques RB; de Ridder CMA; Bubendorf L; Thalmann GN; Brennen WN; Santer FR; Moser PL; Shepherd P; Efstathiou E; Xue H; Lin D; Buijs J; Bosse T; Collins A; Maitland N; Buzza M; Kouspou M; Achtman A; Taylor RA; Risbridger G; Corey E
    Prostate; 2018 Dec; 78(16):1262-1282. PubMed ID: 30073676
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 deficiency linked to B cell translocation gene 2 (BTG2) loss enhances metastatic potential by promoting tumor growth in primary and metastatic sites in patient-derived xenograft (PDX) models of triple-negative breast cancer.
    Powell E; Shao J; Yuan Y; Chen HC; Cai S; Echeverria GV; Mistry N; Decker KF; Schlosberg C; Do KA; Edwards JR; Liang H; Piwnica-Worms D; Piwnica-Worms H
    Breast Cancer Res; 2016 Jan; 18(1):13. PubMed ID: 26818199
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neuroblastoma patient-derived orthotopic xenografts reflect the microenvironmental hallmarks of aggressive patient tumours.
    Braekeveldt N; Wigerup C; Tadeo I; Beckman S; Sandén C; Jönsson J; Erjefält JS; Berbegall AP; Börjesson A; Backman T; Øra I; Navarro S; Noguera R; Gisselsson D; Påhlman S; Bexell D
    Cancer Lett; 2016 Jun; 375(2):384-389. PubMed ID: 27000989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Capturing colorectal cancer inter-tumor heterogeneity in patient-derived xenograft (PDX) models.
    Prasetyanti PR; van Hooff SR; van Herwaarden T; de Vries N; Kalloe K; Rodermond H; van Leersum R; de Jong JH; Franitza M; Nürnberg P; Todaro M; Stassi G; Medema JP
    Int J Cancer; 2019 Jan; 144(2):366-371. PubMed ID: 30151914
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.